Norepinephrine Drives Sleep-Dependent Astrocyte Volume Changes in Mouse Cortex

The accumulation of metabolic waste and protein aggregates, such as amyloid-beta and tau, remains a central challenge in the clinical management of neurodegenerative disorders like Alzheimer’s disease [1, 2]. Recent evidence suggests that the glymphatic system, a glial-dependent waste clearance pathway, is primarily active during sleep and degrades significantly with age [3, 4]. This clearance mechanism is supported by the polarization of aquaporin-4 (a water channel protein) on astrocytic endfeet and is influenced by circadian rhythms [5, 6]. While sleep disruption is a known antecedent to cognitive decline, the precise cellular dynamics that govern the expansion and contraction of the brain's interstitial space (the fluid-filled gaps between neurons) across sleep states have remained unclear [3]. A new study using two-photon imaging (a high-resolution fluorescence technique) demonstrates that astrocytes expand during wakefulness and shrink during non-rapid eye movement sleep, a process driven by norepinephrine release from the locus coeruleus (a brainstem nucleus involved in arousal) [7, 8, 9]. These findings suggest that astrocytic expansion during wakefulness reduces the interstitial-volume fraction, thereby suppressing glymphatic flow and increasing neuroglia interactions [8].